Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Texas (Houston, MD Anderson Cancer Center) for the study, removed the old Texas Locations block and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T10:24:03.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.1 to v3.3.2; no study content or critical details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T15:55:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.1. Deleted wording stating that PubMed publications are automatically created by ClinicalTrials.gov with an identifier and may or may not be related to the study; revision updated from v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-23T14:53:58.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page no longer includes the government funding operating status notice in the footer; this change does not affect study details such as eligibility criteria, endpoints, or enrollment.
    Difference
    0.4%
    Check dated 2025-11-16T14:39:49.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and some wording tweaks across sections like Study Overview and Study Plan; core content such as the study title, eligibility criteria, interventions, endpoints, and enrollment remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-02T00:56:49.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    3%
    Check dated 2025-10-04T12:22:39.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.